Leave room for the question you nearly kept back.

“What concern is the assessment about?”

Invite the clinician to describe the concern they are assessing. Ask how you would judge a useful change in your own situation.

“What other choices belong in this conversation?”

Ask about other medicines, other kinds of care and the option of waiting for more information. You can ask why an option is being discussed before agreeing to it.

“What exactly would be prescribed?”

Ask for the ingredient, product name and form in writing. A broad label such as “peptide care” does not answer that question.

“Why consider a compounded preparation?”

FDA explained, as checked September 26, 2026, that a compounded medicine may suit a patient whose medical need an available approved medicine cannot meet.

Ask the clinician to name the unmet need and explain how they identified it in your case.

“Could there be no prescription after the visit?”

Ask what happens to any visit fee if the clinician decides that no medicine is appropriate. Get the payment terms before the appointment.

“Who explains a change or a problem?”

Ask for a clear route back to the clinician and the pharmacy. Write down who handles each kind of question.

“Can we talk about pregnancy plans?”

The medicines semaglutide and tirzepatide have products for weight care and others for blood sugar control.

Their product labels, read September 17, 2026, give different advice about when to stop a medicine in relation to pregnancy.

Bring pregnancy, breastfeeding or pregnancy plans into the discussion with your own clinician.

“What have I not thought to ask?”

Leave a little space at the end. You can ask for a word to be explained, an answer in writing or time to think.